China approves 16 locally-made Covid-19 vaccines for clinical trials
Filed in Shanghai Travel News on February 21, 2021 with no comments
February 21, 2021 ×
China has approved clinical trials for 16 indigenous Covid-19 vaccines, of which six are in the third stage, according to a state-run media report.
The latest vaccines for clinical trials are based on recombinant protein, adenovirus vector, nucleic acid and attenuated influenza-viruses technologies, state-run Xinhua news agency reported on Saturday, citing data from the National Medical Products Administration.…
This data comes from the ChinaPulse.com media intelligence and smart news insights platform.